Cargando…
Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease Drug Development
Human induced pluripotent stem (iPS) cells have the potential to give rise to a new era in Parkinson’s disease (PD) research. As a unique source of midbrain dopaminergic (DA) neurons, iPS cells provide unparalleled capabilities for investigating the pathogenesis of PD, the development of novel anti-...
Autores principales: | Antonov, S. A., Novosadova, E. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037675/ https://www.ncbi.nlm.nih.gov/pubmed/33806103 http://dx.doi.org/10.3390/ijms22073381 |
Ejemplares similares
-
Influence of N-Arachidonoyl Dopamine and N-Docosahexaenoyl Dopamine on the Expression of Neurotrophic Factors in Neuronal Differentiated Cultures of Human Induced Pluripotent Stem Cells under Conditions of Oxidative Stress
por: Novosadova, Ekaterina, et al.
Publicado: (2022) -
Unresolved theoretical problems
por: Vogt, E W
Publicado: (1983) -
Transcriptome Analysis of Induced Pluripotent Stem Cells and Neuronal Progenitor Cells, Derived from Discordant Monozygotic Twins with Parkinson’s Disease
por: Vlasov, Ivan N., et al.
Publicado: (2021) -
Unresolved problems with distress screening
por: Fielding, R, et al.
Publicado: (2013) -
The Unresolved Problem of DNA Bridging
por: Fernández-Casañas, María, et al.
Publicado: (2018)